FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
|
ALS News & Research For postings of news or research links and articles related to ALS |
|
Thread Tools | Display Modes |
![]() |
#1 | |||
|
||||
Grand Magnate
|
Neuraltus Pharmaceuticals Provides Enrollment Update on Confirmatory Phase 2 Study of NP001 in ALS
Neuraltus Pharmaceuticals Provides Enrollment Update on Confirmatory Phase 2 Study of NP 1 in ALS |
|||
![]() |
![]() |
|
|
![]() |
||||
Thread | Forum | |||
Neuraltus Pharmaceuticals Initiates Confirmatory Phase 2 Study of NP001 in Patients w | ALS News & Research | |||
Neuraltus Pharmaceuticals Announces Plans 2nd Phase 2 Study of NP001 in ALS . . . | ALS News & Research | |||
NeuroDerm Announces Enrollment in a 2nd Phase 2 Study of ND0612 - Continuous L/C Drug | Parkinson's Disease | |||
NeuroDerm Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Ca | Parkinson's Disease |